Medicine
Gvoke VialDx 1 mg/0.2 mL injection
Gvoke VialDx 1 mg/0.2 mL injection is a prescription medicine containing Glucagon for intravenous use, marketed by American Regent, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not refrigerate or freeze. Store GVOKE HypoPen, GVOKE PFS, and GVOKE Kit…
Key facts
- Active ingredient (INN)
- Glucagon
- Brand
- Gvoke VialDx
- Strength
- 1 mg/0.2 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 0.2 mL, 10 vials of 0.2 mL
- Marketing authorisation holder
- American Regent
- Manufacturer
- American Regent
- Origin register
- US FDA, United States
- Storage
- Do not refrigerate or freeze. Store GVOKE HypoPen, GVOKE PFS, and GVOKE Kit (these three presentations are referred to as GVOKE in this labeling), and GVOKE VialDx at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H04AA01 Glucagon
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 19 August 2025
- Identifiers
- RxCUI 2587358, 2587361DailyMed set ID 359982a8-ec5c-4927-8c0f-89771e0f942bNDC 0517-2901Application NDA212097
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / .2 mL in 1 vial | 0517-2901-01 | American Regent | 19 August 2025 |
| 10 vial in 1 carton / .2 mL in 1 vial | 0517-2901-10 | American Regent | 19 August 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Glucagon 1 mg/0.2 mL injection.
- Gvoke HypoPen 1 mg Auto-Injector 1 mg/0.2 mL injectionAvailable on requestXeris PharmaceuticalsUS FDA2 packs
- Gvoke PFS 1 mg Pre-filled Syringe 1 mg/0.2 mL injectionAvailable on requestXeris PharmaceuticalsUS FDA2 packs
- Gvoke Kit 1 mg/0.2 mL injectionAvailable on requestXeris PharmaceuticalsUS FDA1 pack
Other strengths and forms of Glucagon
Clinical summary
Glucagon is an antihypoglycemic agent. It is available as injection, kits and powder for intravenous, subcutaneous and intramuscular use. MedsAcross supplies Glucagon for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about GlucagonFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Glucagon prescribing information (Fresenius Kabi) · U.S. National Library of Medicine, DailyMed
- Baqsimi: European public assessment report (EPAR) · European Medicines Agency
- Ogluo: European public assessment report (EPAR) · European Medicines Agency
Need Gvoke VialDx 1 mg/0.2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.